Skip to content
2000
Volume 7, Issue 1
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Almost a decade ago, it was discovered that the human deficiency virus (HIV) makes use of chemokine receptors to infect blood cells. This appreciation of the clinical relevance of specific chemokine receptors has initiated a considerable boost in the field of chemokine research. It is clear today that chemokine signaling orchestrates the immune system and is widely involved in both physiological and pathophysiological processes. Since the chemokine system offers various targets through which pathology could be influenced, most pharmaceutical companies have chosen this system as a therapeutic target for a variety of diseases. Here recent developments concerning the role of chemokines in diseases of the central nervous system (CNS) as well as their possible therapeutic relevance are discussed.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945006775270196
2006-01-01
2025-09-07
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945006775270196
Loading

  • Article Type:
    Research Article
Keyword(s): AIDS; astrocytes; Hippocampal neurons; ICAM-1; ischemic cell death; microglia
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test